These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 9512115

  • 1. Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor.
    Haga Y, Nakatsura T, Shibata Y, Sameshima H, Nakamura Y, Tanimura M, Ogawa M.
    Dig Dis Sci; 1998 Feb; 43(2):253-7. PubMed ID: 9512115
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic effects of lansoprazole on peptic ulcers in elderly patients.
    Murakami M, Saita H, Takahashi Y, Kusaka S, Asagoe K, Dekigai H, Matsumoto M, Seki M, Mizuno M, Maeda S.
    J Clin Gastroenterol; 1995 Feb; 20 Suppl 2():S79-82. PubMed ID: 7594348
    [Abstract] [Full Text] [Related]

  • 4. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Feb; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 5. Drug therapy of peptic ulcer disease.
    Ching CK, Lam SK.
    Br J Hosp Med; 1993 Feb; 54(2-3):101-6. PubMed ID: 7551483
    [Abstract] [Full Text] [Related]

  • 6. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M, Ashida K, Umegaki E, Miyoshi H, Katsu K.
    J Clin Gastroenterol; 1995 Feb; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor.
    Kaneko E, Hoshihara Y, Sakaki N, Harasawa S, Ashida K, Asaka M, Asaki S, Nakamura T, Kobayashi K, Kajiyama G, Ogawa N, Yao T, Muto Y, Nakazawa S, Takemoto T.
    J Gastroenterol; 2000 Feb; 35(11):824-31. PubMed ID: 11085491
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Proton-pump inhibitors: three of a kind?
    Bateman DN.
    Lancet; 1997 Jun 07; 349(9066):1637-8. PubMed ID: 9186377
    [No Abstract] [Full Text] [Related]

  • 11. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K, Ueki N, Suzuki K, Shinji Y, Kusunoki M, Hiratsuka T, Nishigaki H, Tatsuguchi A, Futagami S, Wada K, Tsukui T, Nakajima A, Yoshino S, Sakamoto C.
    Aliment Pharmacol Ther; 2005 Jun 07; 21 Suppl 2():67-72. PubMed ID: 15943850
    [Abstract] [Full Text] [Related]

  • 12. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
    Sasakii M, Joh T, Yokoyama Y, Seno K, Tsuchida K, Kurokawa T, Itoh M.
    J Pharm Pharmacol; 1999 Jul 07; 51(7):825-30. PubMed ID: 10467958
    [Abstract] [Full Text] [Related]

  • 13. Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
    Tanaka M, Maruoka A, Chijiiwa Y, Tanaka M, Nawata H.
    Scand J Gastroenterol; 1994 Dec 07; 29(12):1140-4. PubMed ID: 7886404
    [Abstract] [Full Text] [Related]

  • 14. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
    Asaka M, Kato M, Sato Y, Miyazaki T.
    Nihon Rinsho; 1992 Jan 07; 50(1):104-10. PubMed ID: 1347322
    [Abstract] [Full Text] [Related]

  • 15. Endosonographic evaluation of the quality of ulcer healing induced by proton pump inhibitors.
    Tsukamoto Y, Goto H, Hase S, Niwa Y, Arisawa T, Hayakawa T, Yoshikane H.
    J Clin Gastroenterol; 1995 Jan 07; 20 Suppl 2():S40-3. PubMed ID: 7594337
    [Abstract] [Full Text] [Related]

  • 16. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
    Hotz J, Kleinert R, Grymbowski T, Hennig U, Schwarz JA.
    Aliment Pharmacol Ther; 1992 Feb 07; 6(1):87-95. PubMed ID: 1543819
    [Abstract] [Full Text] [Related]

  • 17. Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine.
    Tsuji S, Kawano S, Higashi T, Mukuda T, Imaizumi T, Tatsumi T, Miura N, Miyajima K, Fukuda M, Noguchi M.
    J Clin Gastroenterol; 1995 Feb 07; 20 Suppl 2():S1-4. PubMed ID: 7594320
    [Abstract] [Full Text] [Related]

  • 18. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL, Jia JC, Li YL, Yang GB.
    J Int Med Res; 2003 Feb 07; 31(6):469-74. PubMed ID: 14708410
    [Abstract] [Full Text] [Related]

  • 19. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW.
    Am J Health Syst Pharm; 1999 Dec 01; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [Abstract] [Full Text] [Related]

  • 20. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
    Okai T, Sawabu N, Songür Y, Motoo Y, Watanabe H.
    J Clin Gastroenterol; 1995 Dec 01; 20 Suppl 2():S32-5. PubMed ID: 7594335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.